CausalSentinel

Protein Dossier — CAT (Catalase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: C61 Malignant neoplasm of prostate 0.152 0.06 0.0113 Wald ratio 1 cis NA
Ischemic stroke -0.0918 0.0374 0.0141 Wald ratio 1 cis NA
Neo-openness to experience -0.318 0.162 0.049 Wald ratio 1 cis NA
Pulse rate 0.0189 0.01 0.0589 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.135 0.0715 0.0592 Wald ratio 1 cis NA
Cardioembolic stroke -0.139 0.0736 0.0593 Wald ratio 1 cis NA
Large vessel disease -0.145 0.0795 0.068 Wald ratio 1 cis NA
Non-cancer illness code self-reported: arthritis (nos) -0.136 0.0752 0.0708 Wald ratio 1 cis NA
Neuroticism 0.0176 0.00979 0.0719 Wald ratio 1 cis NA
Years of schooling 0.0176 0.00979 0.0719 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast -0.0871 0.0484 0.0721 Wald ratio 1 cis NA
Hirschsprung’s disease 0.446 0.25 0.0739 Wald ratio 1 cis NA
…and 87 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3488_64_2 Catalase Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

16 association rows across 8 traits (14 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
CAT protein levels 7e-117 rs7113917 4 GCST90468551 no MR -> candidate analysis
Catalase levels 8e-80 rs769218 5 GCST90246842 no MR -> candidate analysis
Core binding factor acute myeloid leukemia 2e-25 rs12786782; rs10768074; rs11032686; rs7111765; rs11032695; rs16925514; rs6484720; rs12295136; rs208681; rs7944397; rs208682; rs208683; rs12807961; rs12808450; rs554518; rs1107573 2 GCST008413 no MR -> candidate analysis
Type 2 diabetes 9e-25 rs1001179 1 GCST90134620 MR: beta=0.151, p=0.294 (cis)
Blood protein levels 1e-20 rs7933285 1 GCST006585 no MR -> candidate analysis
Major depressive disorder or hospitalized COVID-19 (pleiotro 3e-9 rs7118388 1 GCST90296444 no MR -> candidate analysis
Eugenol sulfate levels in elite athletes 4e-6 rs16925614 1 GCST90134213 no MR -> candidate analysis
COVID-19 (hospitalized covid vs population) 5e-6 rs1001179 1 GCST90454507 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1561 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
acatalasia 0.75 established (curated) no MR -> candidate analysis
type 2 diabetes mellitus 0.553 common-variant locus no MR -> candidate analysis
COVID-19 0.421 common-variant locus no MR -> candidate analysis
major depressive disorder 0.386 common-variant locus no MR -> candidate analysis
narcolepsy 0.362 common-variant locus no MR -> candidate analysis
Intellectual disability 0.198 established (curated) no MR -> candidate analysis
vitiligo 0.034 common-variant locus no MR -> candidate analysis

Of the 7 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Catalase)
gnomAD constraint pLI=3.8e-11, LOEUF=0.94 — LoF-tolerant
GWAS Catalog 68 unique SNPs / 135 rows
ClinVar 113 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx 2 clinical annotations across 2 drugs

Caveats declared by the tools

Sources

Provenance